Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the future.

Carroll KM, Ball SA, Jackson R, Martino S, Petry NM, Stitzer ML, Wells EA, Weiss RD.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):275-82. doi: 10.3109/00952990.2011.596978.

2.

The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment.

Tai B, Straus MM, Liu D, Sparenborg S, Jackson R, McCarty D.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S4-13. doi: 10.1016/j.jsat.2010.01.011.

3.

Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network.

Campbell AN, Nunes EV, Miele GM, Matthews A, Polsky D, Ghitza UE, Turrigiano E, Bailey GL, VanVeldhuisen P, Chapdelaine R, Froias A, Stitzer ML, Carroll KM, Winhusen T, Clingerman S, Perez L, McClure E, Goldman B, Crowell AR.

Contemp Clin Trials. 2012 Mar;33(2):386-95. doi: 10.1016/j.cct.2011.11.001. Epub 2011 Nov 9.

4.

NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.

Tross S, Campbell AN, Calsyn DA, Metsch LR, Sorensen JL, Shoptaw S, Haynes L, Woody GE, Malow RM, Brown LS Jr, Feaster DJ, Booth RE, Mandler RN, Masson C, Holmes BW, Colfax G, Brooks AJ, Hien DA, Schackman BR, Korthuis PT, Miele GM; Clinical Trials Network HIV Special Interest Group..

Am J Drug Alcohol Abuse. 2011 Sep;37(5):283-93. doi: 10.3109/00952990.2011.596977.

5.

Quality assurance of research protocols conducted in the community: the National Institute on Drug Abuse Clinical Trials Network experience.

Rosa C, Campbell A, Kleppinger C, Sampson R, Tyson C, Mamay-Gentilin S.

Clin Trials. 2009 Apr;6(2):151-61. doi: 10.1177/1740774509102560.

6.

Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: a summary of findings.

Greenfield SF, Rosa C, Putnins SI, Green CA, Brooks AJ, Calsyn DA, Cohen LR, Erickson S, Gordon SM, Haynes L, Killeen T, Miele G, Tross S, Winhusen T.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):301-12. doi: 10.3109/00952990.2011.596875.

7.

Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection.

Potter JS, Donovan DM, Weiss RD, Gardin J, Lindblad R, Wakim P, Dodd D.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):400-7. doi: 10.3109/00952990.2011.596975.

8.

Increasing ethnic minority participation in substance abuse clinical trials: lessons learned in the National Institute on Drug Abuse's Clinical Trials Network.

Burlew K, Larios S, Suarez-Morales L, Holmes B, Venner K, Chavez R.

Cultur Divers Ethnic Minor Psychol. 2011 Oct;17(4):345-56. doi: 10.1037/a0025668.

9.

A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network.

Roman PM, Abraham AJ, Rothrauff TC, Knudsen HK.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S44-52. doi: 10.1016/j.jsat.2009.12.008.

10.

Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network.

Martino S, Brigham GS, Higgins C, Gallon S, Freese TE, Albright LM, Hulsey EG, Krom L, Storti SA, Perl H, Nugent CD, Pintello D, Condon TP.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S31-43. doi: 10.1016/j.jsat.2009.12.013.

11.

Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?

Nunes EV, Ball S, Booth R, Brigham G, Calsyn DA, Carroll K, Feaster DJ, Hien D, Hubbard RL, Ling W, Petry NM, Rotrosen J, Selzer J, Stitzer M, Tross S, Wakim P, Winhusen T, Woody G.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S97-112. doi: 10.1016/j.jsat.2010.01.012.

12.

The relationship between Clinical Trial Network protocol involvement and quality of substance use disorder treatment.

Abraham AJ, Knudsen HK, Roman PM.

J Subst Abuse Treat. 2014 Feb;46(2):232-7. doi: 10.1016/j.jsat.2013.08.021. Epub 2013 Sep 27.

13.

Conducting research with racial/ethnic minorities: methodological lessons from the NIDA Clinical Trials Network.

Burlew AK, Weekes JC, Montgomery L, Feaster DJ, Robbins MS, Rosa CL, Ruglass LM, Venner KL, Wu LT.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):324-32. doi: 10.3109/00952990.2011.596973.

14.

Study results from the Clinical Trials Network's first 10 years: where do they lead?

Wells EA, Saxon AJ, Calsyn DA, Jackson TR, Donovan DM.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S14-30. doi: 10.1016/j.jsat.2009.12.009.

15.

The design and analysis of multisite effectiveness trials: a decade of progress in the National Drug Abuse Clinical Trials Network.

Nunes EV.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):269-72. doi: 10.3109/00952990.2011.604109. No abstract available.

16.

How practice and science are balanced and blended in the NIDA Clinical Trials Network: the bidirectional process in the development of the STAGE-12 protocol as an example.

Donovan DM, Daley DC, Brigham GS, Hodgkins CC, Perl HI, Floyd AS.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):408-16. doi: 10.3109/00952990.2011.596970.

17.

Research network involvement and addiction treatment center staff: counselor attitudes toward buprenorphine.

Knudsen HK, Ducharme LJ, Roman PM.

Am J Addict. 2007 Sep-Oct;16(5):365-71.

PMID:
17882607
18.

MET meets the real world: design issues and clinical strategies in the Clinical Trials Network.

Carroll KM, Farentinos C, Ball SA, Crits-Christoph P, Libby B, Morgenstern J, Obert JL, Polcin D, Woody GE.

J Subst Abuse Treat. 2002 Sep;23(2):73-80. Review.

19.

The national drug abuse treatment clinical trials network data share project: website design, usage, challenges, and future directions.

Shmueli-Blumberg D, Hu L, Allen C, Frasketi M, Wu LT, Vanveldhuisen P.

Clin Trials. 2013;10(6):977-86. doi: 10.1177/1740774513503522. Epub 2013 Oct 1.

20.

Assessing drug use during follow-up: direct comparison of candidate outcome definitions in pooled analyses of addiction treatment studies.

Korte JE, Magruder KM, Chiuzan CC, Logan SL, Killeen T, Bandyopadhyay D, Brady KT.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):358-66. doi: 10.3109/00952990.2011.602997.

Supplemental Content

Support Center